Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pan-cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06585488
What this trial is testing

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Who this might be right for
Metastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Colorectal Cancer+4 more
BeOne Medicines 47
Not applicableStudy completedNCT03172572
What this trial is testing

A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers

Who this might be right for
Pancreatic NeoplasmsPancreas CystPancreas Cancer
S (Sjors) Klompmaker, MD 4,220
Not applicableLooking for participantsNCT01499394
What this trial is testing

Caris Biorepository Research Protocol

Who this might be right for
CancerEarly Detection of CancerMinimal Residual Disease
Caris Science, Inc. 100,000
Not applicableStudy completedNCT04972201
What this trial is testing

A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy

Who this might be right for
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2,305
Early research (Phase 1)Ended earlyNCT03065387
What this trial is testing

Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation

Who this might be right for
Advanced Malignant Solid NeoplasmEGFR Gene AmplificationEGFR Gene Mutation+7 more
M.D. Anderson Cancer Center 84
Not applicableUnknownNCT05159544
What this trial is testing

The FuSion Program: A Prospective and Multicenter Cohort Study of Pan-Cancer Screening in Chinese Population

Who this might be right for
Cancer
Singlera Genomics Inc. 60,000
Early research (Phase 1)Study completedNCT01121575
What this trial is testing

Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Pfizer 70
Not applicableStudy completedNCT02864563
What this trial is testing

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification

Who this might be right for
Neuroblastoma
Institut Curie 560
Not applicableUnknownNCT04817306
What this trial is testing

Pan-canceR Early DetectIon projeCT (PREDICT)

Who this might be right for
Cancer
Shanghai Zhongshan Hospital 14,026
Testing effectiveness (Phase 2)Looking for participantsNCT04775485
What this trial is testing

Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

Who this might be right for
Low-grade GliomaAdvanced Solid Tumor
Day One Biopharmaceuticals, Inc. 141
Early research (Phase 1)Looking for participantsNCT07458347
What this trial is testing

Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Who this might be right for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC)KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC)KRAS-mutant Colorectal Cancer (CRC)+1 more
Kestrel Therapeutics, Inc. 145
Early research (Phase 1)Study completedNCT01570296
What this trial is testing

A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR

Who this might be right for
Non-Small Cell Lung CancerSolid Tumors
National Cancer Centre, Singapore 38
Testing effectiveness (Phase 2)Looking for participantsNCT03899155
What this trial is testing

Pan Tumor Rollover Study

Who this might be right for
Cancer
Bristol-Myers Squibb 1,500
Testing effectiveness (Phase 2)WithdrawnNCT05041972
What this trial is testing

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

Who this might be right for
HER2 Mutation-Related TumorsHER2 Amplified Solid Tumors
Ambrx, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07688356
What this trial is testing

Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors

Who this might be right for
Primary Brain TumorMetastatic Brain Tumor
Samsung Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT03668119
What this trial is testing

Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

Who this might be right for
Pan Tumor
Bristol-Myers Squibb 212
Early research (Phase 1)Study completedNCT03255070
What this trial is testing

A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)

Who this might be right for
Breast NeoplasmsGastric NeoplasmSolid Tumors
Ambrx, Inc. 106
Large-scale testing (Phase 3)Not Yet RecruitingNCT07336953
What this trial is testing

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
West China Hospital 198
Testing effectiveness (Phase 2)UnknownNCT02268747
What this trial is testing

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Who this might be right for
Skin Squamous Cell Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 43
Early research (Phase 1)Study completedNCT01608009
What this trial is testing

[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer

Who this might be right for
Ovarian Neoplasm
Imperial College London 16
Next Page